Bronchiectasis is characterized by dilatation of bronchi, airflow limitation and chronic infection/inflammation. The aetiology, pathology and management are discussed in this review.
InTRoducTIon
Bronchiectasis is a condition where destruction and damage of bronchioles lead to chronic airflow obstruction and typically copious expectoration. It is characterized by permanent dilation of bronchi and bronchioles caused by destruction of the muscle and elastic tissue, resulting from or associated with chronic necrotizing infection. 1 This was first described by Laennec in 1819 and identified tuberculosis and pertussis as the most likely causes. 2 It is difficult to be sure of the true prevalence of bronchiectasis.
Various epidemiological studies have suggested prevalence of 1.3 per thousand to 17.8 per thousand. [3] [4] [5] [6] The prevalence rises with increasing age. Studies from USA suggested prevalence of 4.2 per thousand in ages 18-34 , rising to 271.8 per thousand in people aged over 75. 6 Bronchiectasis has traditionally been described as one of the obstructive airways disease along with Chronic obstructive airways disease and Asthma. However it is a distinct entity from pathological viewpoint. The destruction of wall of bronchioles which is seen in bronchiectasis is possibly an end product of repeated infection caused by some defect in immune system or some local defect caused by structural abnormality. This leads to chronic inflammation and excessive mucus production which are typical of bronchiectasis.
AeTIology
There are a wide ranges of conditions that can cause
bronchiectasis. An approach based on pathological process appears to be logical and is described in the table 1.
clInIcAl PResenTATIon
Cough productive of sputum is the most common symptom associated with bronchiectasis. [8] [9] [10] [11] [12] Typically sputum is copious in amount and expectoration could be positional. Other symptoms are haemoptysis, breathlessness, chest pain and fever. Crackles associated with some wheeze are the most common clinical findings. Finger clubbing is said to be a feature associated with bronchiectasis and is usually associated with severe disease.
hIsToPAThology
Histopathologically bronchiectatic airways appear dilated and on examination have a cross sectional area that is much larger than accompanying pulmonary artery. 13 The airway lumen is filled with a mucopurulent exudates with neutrophils and macrophages. The bronchial wall is often destroyed due to loss of fibromuscular tissues and the elasic framework, and may show erosion and loss of cartilage. 14 There is an associated chronic inflammatory cell infiltrate within the wall, predominantly lymphocytes and plasma cells, and in some cases lymphoid follicles with germinal centres may be prominent. 15 The airways are supplied by the bronchial arteries and the inflammatory destruction and healing processes result in the formation of broncho-pulmonary anastomoses.
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Ulceration of the airways could lead to haemorrhage and haemoptysis.
The pathogenesis is complex and many different factors act together to set up a cycle of inflammation and destruction that leads to damage and destruction of the bronchial walls. 16 In the early stage of bronchiectasis, the most common bacterial isolate is Haemophilus influenza which has the capacity to damage the airway epithelium and induce the production of inflammatory mediators. There is emerging evidence that mannitol is an effective treatment in non CF bronchiectasis. Daviskas et al showed improved health related quality of life with its use and it is well tolerated.
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Evidence base for n-Acetyl cysteine is very limited. Dornase-alfa may be harmful in non cystic fibrosis bronchiectasis althogh it is well established in cystic fibrosis. 31 The evidence base for long term humidification is weak. Rea et al showed fewer exacerbation days, improved quality of life and lung functions. There was no significant decrease in exacerbation frequency. Chest physiotherapy and mucus clearance are the mainstay of management strategy.
